5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice. - Wikidata - wikimedia - TriplyDB

5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

http://www.wikidata.org/entity/Q34035255

about

Functionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosis HDL in sepsis - risk factor and therapeutic approach Novel concepts in HDL pharmacology.Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation.Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G(*) apolipoprotein J peptide using solution NMR.5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice.A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice New kids on the block: the emerging role of apolipoproteins in the pathogenesis and treatment of asthma.Regulation of ABCA1 functions by signaling pathways Helix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter.Apolipoprotein mimetic peptides: a new approach for the treatment of asthma.The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies.Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter.Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts.Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.Recombinant high-density lipoprotein formulations.Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur.High-density lipoprotein mimetics: promises and challenges.The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease.High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut?Apolipoprotein A1 potentiates lipoxin A4 synthesis and recovery of allergen-induced disrupted tight junctions in the airway epithelium.

P2860

Q24603711-46E2CFFF-3EBC-408A-AE93-4B12ED1C3D3A Q26777964-45AFD232-2465-4D2B-8811-70E4F7A183DF Q27692691-A1F02CA0-17CC-4B88-8E9B-CAE93FC76D86 Q28546760-3A234D07-203F-481C-8741-A5CB89A774AD Q30251918-59616E7B-455E-4EBF-ADCB-FA26E1CDBD13 Q33356762-019B721B-E9C3-40A9-99BD-1143B17EEC54 Q34155049-6B2BDD26-360D-4BEC-9E7A-3BC82203C000 Q34384359-1D467B39-0A40-4248-8134-D2C5F87483A6 Q34449116-C6A08908-4B09-421F-A1A3-D110FE9A9300 Q34594140-CF267053-38B3-4825-957F-DE2DF600B3FD Q34781496-C365C106-4C6D-4C81-8ED0-79FDEAC0D3BA Q34851167-8C03F17C-4EED-4C21-8788-321AFE7F592F Q34946523-E7DBE569-57EE-4075-915F-7EC96D586898 Q35267682-4EB8540D-D367-43F9-8082-A27AED6B4063 Q35626943-D3CE6762-F512-4236-8411-B4591FF18DBE Q35660283-DD39484E-0F77-448D-8B8C-D1EB11EC3145 Q35815986-E20F6E07-482F-4B6E-B4AB-57F2BF92B514 Q35994365-2270B1D6-3803-4133-BBAF-66FD2F6AE478 Q36007212-90EC00D0-5EB8-41E4-983A-95C22CB0B65E Q36145207-6EADC05A-CE93-40CA-B7CD-60AA13FF1E7F Q36497600-7F9F3F60-4256-4075-960F-742BAF401FBA Q36503047-0D771CF8-00A0-404B-9F73-642202BB62A9 Q36707848-ECBBA51D-08DA-48B5-848C-3FB78A8182DC Q36761029-B85374BD-115B-4CB7-B888-7CDA820BBF34 Q36772356-6350CBFE-E481-4CB6-A83E-C917BB5532D0 Q37224981-E961A19D-2A73-4386-BC35-EBFEE0F24F07 Q37329233-CB662E6A-27D7-4DE3-874F-6D9C7A7A516A Q37446423-F06152DD-6979-485A-AFBB-F99EC2257876 Q37528535-EBDE8435-D80D-44C2-96F9-267CC528F731 Q37661249-A1187571-398E-4AC7-AC4E-CB39CBD1B38B Q37807911-14754701-CF70-4C9D-8470-B806AE858A1E Q38266911-54E14904-C943-4EFB-AD50-D3EBEACD89B3 Q38650575-673B699D-AD73-4F71-81A3-DA9EDA63A780 Q38767234-DC61A7A2-1BC8-4076-8EC9-9E5943606EC0 Q38965138-EB89F6A5-E07D-4FB5-82DC-B3298F019013 Q41341405-7275E961-9303-442A-BEAA-A9E7AD7595C7 Q42150261-C095B8AD-2418-4189-8D9B-E03371302C44 Q42791504-687030BE-651F-4E33-87A0-FF9119E2933C Q42913663-75C8B1E1-694D-4A21-832D-6600186C510E Q47929030-D3997E7A-60D1-4977-8C22-BD41679F7D84

P2860

5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

http://www.wikidata.org/entity/Q34035255

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@ast

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@en

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@nl

type

label

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@ast

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@en

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@nl

prefLabel

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@ast

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@en

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@nl

P1433

Q34035255-6DC663A0-DFB0-4A09-864B-0B2372EEDB83

P1476

Q34035255-0EB93DB2-3EA5-4A3C-ABD0-8E48AA2197D9

P2093

Q34035255-19D1C838-AE6A-46F2-9557-50F364CC9489

Q34035255-2FDE4088-CD3C-43AA-8488-CA8939E7E882

Q34035255-55D0A053-2138-427D-9F17-FE8F64B8410C

Q34035255-5F368E54-CD1E-4C62-A598-22F43EBD76BC

Q34035255-7E7B5760-5A64-41DF-8756-98B50B58F06B

Q34035255-7FB9242D-EC45-492B-B4EF-B37E7C3975EA

Q34035255-86AFFEE6-205A-4515-94B8-D18DA7DA20E2

Q34035255-9E61E92A-A9A1-4C7D-B374-7FB8452DFF6E

Q34035255-A5695749-1DB2-445E-85E4-474920ED5BDC

Q34035255-D2327B5B-535F-41BD-BB8B-B8E75E18520C

P2860

Q34035255-013E7974-51A5-4F4D-81F9-CACF87CF2DEC

Q34035255-08B8CA74-6EBE-4686-A982-7DFB99D19802

Q34035255-0E16DA79-6886-454A-BB46-81C4175866FB

Q34035255-0F2B91B4-730A-440A-AA36-5FB34752DFF6

Q34035255-14777A33-229C-4B40-9C27-82673373B29D

Q34035255-225E6C36-B44B-4244-B0D0-3F9862A4202F

Q34035255-288B7A40-20FE-44C4-8D07-37FF480A5D38

Q34035255-28C7046D-FFEA-4F19-B51A-DA9B29DDE85A

Q34035255-2BF2D6F5-305E-4E3C-AA66-2ABDCC1DE2FB

Q34035255-30F8E48B-4F08-48EF-B693-821AEB8940D7

P304

Q34035255-5C14D552-2829-45D2-B701-FF644DED75F2

P31

Q34035255-85DE128D-4C68-49E9-ABC9-0FC2AE8FEAAD

P356

Q34035255-E1BAB058-A817-4210-91C0-073CD441AC49

P407

Q34035255-54FCD7F1-AE5A-4AA1-84C7-EF3FF1156A15

P433

Q34035255-91A969BC-FA1C-4844-AF15-0BE8B315D016

P478

Q34035255-331C2F93-ED3C-4B20-AA66-6188833D1E8C

P577

Q34035255-FE2FD04A-2C4A-431F-968B-C166F1778141

P5875

Q34035255-C5235695-AEFC-4934-B77B-71C0B6914F0F

P698

Q34035255-C700B587-059E-4AF4-B25F-DBE994C747B1

P921

Q34035255-7F251F01-59C5-47C2-AD3B-F8105AA17D28

P932

Q34035255-07F8FFCE-1319-4BE1-B348-2E6930ACB2AE

P356

JPET.110.167890

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

5A apolipoprotein mimetic pept ...... duces atherosclerosis in mice.

@en

P2093

Alan T Remaley

http://www.w3.org/2001/XMLSchema#string

Denis Sviridov

http://www.w3.org/2001/XMLSchema#string

Dmitri Sviridov

http://www.w3.org/2001/XMLSchema#string

Jason Voogt

http://www.w3.org/2001/XMLSchema#string

Jayraz Luchoomun

http://www.w3.org/2001/XMLSchema#string

John Stonik

http://www.w3.org/2001/XMLSchema#string

Marc Hellerstein

http://www.w3.org/2001/XMLSchema#string

Marcelo J A Amar

http://www.w3.org/2001/XMLSchema#string

Scott Turner

http://www.w3.org/2001/XMLSchema#string

Stephen Demosky

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein specificity for lipid efflux by the human ABCAI transporter

The role of different regions of ATP-binding cassette transporter A1 in cholesterol efflux

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

A simple method for the isolation and purification of total lipides from animal tissues

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice

The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.

Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo.

HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice

P304

634-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.110.167890

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

334

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44613345

http://www.w3.org/2001/XMLSchema#string

P698

20484557

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2913774

http://www.w3.org/2001/XMLSchema#string